600833.SHG Shanghai No1 Pharmacy Co Ltd
- Market cap
- CNY 2.13B
- P/E
- 68.3x
- P/B
- 1.85x
- ROE
- 3.2%
- Dividend yield
- 2.38%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 600833.SHG undervalued?
Graham number600833.SHG trades 136.9% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Shanghai No1 Pharmacy Co Ltd fundamental analysis
No fundamental analysis for Shanghai No1 Pharmacy Co Ltd yet.
Shanghai No1 Pharmacy Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Shanghai No1 Pharmacy Co Ltd
Shanghai No.1 Pharmacy Co.,Ltd., together with its subsidiaries, engages in the retail and wholesale of pharmaceutical products in China. It sells food, medical equipment, health convenience products, and other commodities. The company serves medical institutions, pharmacies, commodity distribution companies, and franchise stores. Shanghai No. 1 Pharmacy Co.,Ltd. was founded in 1992 and is headquartered in Shanghai, China.
Full company profileShanghai No1 Pharmacy Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Shanghai No1 Pharmacy Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 1.52B | 1.56B | 1.18B | 1.24B | 1.59B | 1.40B | 2.66B | 1.82B | 1.92B | 2.13B | 2.03B |
| Gross Profit | 234M | 243M | 226M | 244M | 277M | 245M | 540M | 345M | 317M | 342M | 312M |
| Operating Income | 56.5M | 56.7M | 59.3M | 51.8M | 71.5M | 35.1M | 191M | 99.0M | 208M | 8.51M | -11.1M |
| EBITDA | 67.3M | 66.4M | 68.7M | 78.2M | 101M | 76.2M | 213M | 133M | 229M | 150M | 48.3M |
| Net Income | 46.0M | 43.5M | 47.2M | 53.1M | 68.5M | 49.4M | 144M | 89.3M | 163M | 57.7M | 35.9M |
| EPS | 0.21 | 0.19 | 0.21 | 0.24 | 0.31 | 0.22 | 0.64 | 0.40 | 0.73 | 0.26 | 0.16 |
| Balance Sheet | |||||||||||
| Total Assets | 1.19B | 1.14B | 1.08B | 1.22B | 1.40B | 1.33B | 2.04B | 1.86B | 1.98B | 2.02B | 1.91B |
| Total Liabilities | 449M | 422M | 410M | 484M | 647M | 557M | 1.08B | 855M | 836M | 850M | 759M |
| Shareholders' Equity | 729M | 707M | 663M | 725M | 742M | 771M | 952M | 1.00B | 1.14B | 1.16B | 1.14B |
| Cash & Short-term Investments | 228M | 324M | 388M | 474M | 509M | 262M | 725M | 430M | 452M | 323M | 310M |
| Total Debt | 22.5M | 22.5M | 22.5M | - | 181M | 103M | 458M | 267M | 211M | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 36.4M | 120M | 42.8M | 105M | 84.2M | 36.6M | 132M | 58.5M | 49.0M | 88.9M | - |
| Capital Expenditure | 2.61M | 13.6M | 9.13M | 9.99M | 12.2M | 12.6M | 11.4M | 13.9M | 51.9M | 15.9M | 8.61M |
| Free Cash Flow | 33.8M | 106M | 33.7M | 94.6M | 72.0M | 23.9M | 121M | 44.6M | -2.91M | 73.0M | -4.00M |
| Ratios | |||||||||||
| ROE | 6.3% | 6.1% | 7.1% | 7.3% | 9.2% | 6.4% | 15.1% | 8.9% | 14.4% | 5.0% | 3.2% |
| ROA | 3.9% | 3.8% | 4.4% | 4.4% | 4.9% | 3.7% | 7.0% | 4.8% | 8.2% | 2.9% | 1.9% |
| Net Profit Margin | 3.0% | 2.8% | 4.0% | 4.3% | 4.3% | 3.5% | 5.4% | 4.9% | 8.5% | 2.7% | 1.8% |
| Debt to Equity | 0.03x | 0.03x | 0.03x | - | 0.24x | 0.13x | 0.48x | 0.27x | 0.19x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Shanghai No1 Pharmacy Co Ltd dividends
- Dividend yield
- 2.38%
- Forward dividend
- 0.08 CNY
- Payout ratio
- 88.0%
- Ex-dividend date
- Jun 26, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 50.8M | 0.23 | 88.0% |
| 2024 | CNY 29.4M | 0.13 | 18.0% |
| 2023 | CNY 48.2M | 0.22 | 54.0% |
| 2022 | CNY 15.6M | 0.07 | 10.9% |
| 2021 | CNY 22.4M | 0.10 | 45.4% |
| 2020 | CNY 16.7M | 0.08 | 24.4% |
| 2019 | CNY 14.5M | 0.07 | 27.3% |
| 2018 | CNY 13.4M | 0.06 | 28.4% |
| 2017 | CNY 15.6M | 0.07 | 35.9% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 14:10 on Jul 15, 2011.
Who owns Shanghai No1 Pharmacy Co Ltd
- Insiders 52.18%
- Institutions 2.45%
- Public & others 45.37%
- Shares outstanding 223M
- Free float 105M
Shanghai No1 Pharmacy Co Ltd company profile
- Company name
- Shanghai No1 Pharmacy Co Ltd
- Ticker
- 600833.SHG
- ISIN
- CNE000000412
- Exchange
- Shanghai Stock Exchange
- Listed since
- Jun 17, 1992
- Sector
- Healthcare
- Industry
- Consumer Staples Distribution & Retail
- Employees
- 818
- Fiscal year end
- December
- Address
- No. 681 Xiaomuqiao Road, Shanghai, China, 200032
- Phone
- 86 21 64337282
- Website
- shdyyy.com.cn
About Shanghai No1 Pharmacy Co Ltd
Shanghai No.1 Pharmacy Co.,Ltd., together with its subsidiaries, engages in the retail and wholesale of pharmaceutical products in China. It sells food, medical equipment, health convenience products, and other commodities. The company serves medical institutions, pharmacies, commodity distribution companies, and franchise stores. Shanghai No. 1 Pharmacy Co.,Ltd. was founded in 1992 and is headquartered in Shanghai, China.
Shanghai No1 Pharmacy Co Ltd management
7- Mr. Jun YaoVice Chairman & GM · born 1973
- Mr. Zheng SunCFO & Secretary of the Board · born 1975
- Ms. Huayan LinDeputy General Manager · born 1977
- Mr. Hui LiDeputy General Manager
- Ms. Yi Meng ChenDeputy General Manager
- Ms. Yuan JiangDeputy General Manager
- Jie Jing HuangAccounting Supervisor